Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w

WATCH-BPM (comparing a wearable WATCH-type Blood Pressure Monitor with a conventional ambulatory blood pressure monitor and auscultatory sphygmomanometry)
A. Samol1, M. Vaseekaran2, S. Kaese2, D. Görlich3, M. Wiemer2
1Klinik für Innere Medizin I, Kardiologie & Angiologie, St. Antonius Hospital Gronau GmbH, Gronau (Westf.); 2Klinik für Kardiologie und Internistische Intensivmedizin, Johannes Wesling Klinikum Minden, Minden; 3Institute of Biostatistics and Clinical Research, University of Muenster, Münster;

Background: Smart devices, which are able to measure the blood pressure (BP), are valuable for hypertension or heart failure management using digital technology. Data regarding their diagnostic accuracy in comparison to standard non-invasive measurement in accordance to Riva-Rocci are sparse. This study compares a wearable Watch-type BP Monitor (Omron HeartGuide), a conventional ambulatory BP monitor and auscultatory sphygmomanometry.

Patients and Methods: 159 consecutive patients performed observed single measurements with the smart device compared to the auscultatory sphygmomanometry (n=109, 56 female, age 69.8±13.6 years) or multiple measurements during 24 hours compared to a conventional ambulatory BP monitor (n=50, 23 female, age 52.3±14.5 years). The 2 BP monitoring devices were simultaneously worn on the same arm throughout the monitoring period, measurements between the two devices were performed with a delay of 60 seconds.

Results: The intraclass correlation coefficient (ICC) according to Cicchetti in the single measurement group between the difference and the mean values of the Omron HeartGuide and the conventional method was “very good” for systolic blood pressure (SBP) and “good” for diastolic blood pressure (DBP). According to Koo/li ICC was “good” for the SBP and “average” for DBP. There was no correlation between the difference of the SBP or DBP of both devices (Table 1). The ICC according to Cicchetti between the Omron HeartGuide and the ambulatory BP monitor for long-term measurement was “very good” for SBP and DBP. ICC according to Koo/li was “good” for SBP and DBP. There was no correlation between the difference of the SBP or DBP of both devices (Table 1).

Conclusion: The Omron HeartGuide device provides comparable BP values compared to standard devices for single and long-term measurement and is a suitable smartwatch for monitoring or controlling BP with highly reproduceable BP values compared to standard methods in clinical use. The device may allow telemetric treatment observation and improvement in an outpatient setting.


Single blood pressure measurement (n=109 patients)

Omron

RR

Diff. (RR- WBPM)

ICC

SBP, mmHg

132.96 ± 21.10

127 ± 19.18

5.8 ± 17.1

0.765

DBP, mmHg

75.28 ± 11.29

76.41 ± 14.04

0.8 ± 11.7

0.732

Long-term blood pressure measurement (n=811 pairs)

Omron

ABPM

Diff. (ABPM- WBPM)

ICC

SBP, mmHg

119.89 ± 15.05

120.61 ± 15.59

0.72 ± 1.44

0.880

DBP, mmHg

71.28± 9.56

75.54 ± 10.32

4.27 ± 0.97

0.829


Table 1 (SBP=systolic blood pressure; DBP=diastolic blood pressure; RR=Riva-Rocci; WBPM=wearable blood pressure monitor; ICC=intraclass correlation coefficient; ABPM=ambulatory blood pressure monitor)


https://dgk.org/kongress_programme/jt2023/aP2114.html